Clinical Trial

CBD for Lower Urinary Tract Dysfunction in Spinal Cord Injury

Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The goal of this feasibility study is to learn whether Cannabidiol (CBD) can improve urinary incontinence and other symptoms in people with recent spinal cord injury (SCI). Participants will take Epidiolex (purified CBD) for 90 days
Protocol Amendment History 14 amendments
This ClinicalTrials.gov record has been amended 14 times since 2025-02-17; most recent amendment 2026-03-02.
Status change: Not Yet Recruiting → Recruiting 2025-06-30
Trial Details
NCT Number NCT06840899
Lead Sponsor University of Wisconsin, Madison
Conditions Supra-sacral Spinal Cord Injury, Spinal Cord Injury, Urinary Incontinence
Enrollment 20 participants
Start Date 2026-02-13
Primary Completion 2027-05 (estimated)
Study Completion 2027-05 (estimated)
Updated on ClinicalTrials.gov 2026-03-04